CREB - A real culprit in oncogenesis

FEBS Journal

Volumn 274, Issue 13, 2007, Pages 3224-3232

  Siu, Yeung Tung ^a   Jin, Dong Yan ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CREB; Fusion oncoprotein; Human T cell leukemia virus type I oncoprotein Tax; Oncogenesis; Proto oncogene; TORC coactivators

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HYBRID PROTEIN; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; CUSHING SYNDROME; GENE AMPLIFICATION; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; SALIVARY GLAND TUMOR; SHORT SURVEY; T CELL LEUKEMIA; TUMOR CELL; TUMOR SUPPRESSOR GENE; VIRUS TRANSFORMATION;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIMERIZATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34347391261     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05884.x     Document Type: Short Survey

References (94)

1. Shaywitz AJ Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68, 821 861.
2. Mayr B Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2, 599 609.
3. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, Orth AP, Miraglia L, Meltzer J, Garza D et al. (2003) Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 100, 12147 12152.
4. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB Montminy M (2003) TORCs: transducers of regulated CREB activity. Mol Cell 12, 413 423.
5. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD Vinson C (1998) A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol 18, 967 977.
6. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Brechot C Sobczak-Thepot J (1995) Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol 15, 3301 3309.
7. White PC, Shore AM, Clement M, McLaren J, Soeiro I, Lam EW Brennan P (2006) Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes. Oncogene 25, 2170 2180.
8. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G Goodman RH (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041 1054.
9. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102, 4459 4464.
10. Kinjo K, Sandoval S, Sakamoto KM Shankar DB (2005) The role of CREB as a proto-oncogene in hematopoiesis. Cell Cycle 4, 1134 1135.
11. Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM Sakamoto KM (2005) The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7, 351 362.
12. Brown AD, Lopez-Terrada D, Denny C Lee KA (1995) Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. Oncogene 10, 1749 1756.
13. Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Du Granter SRJ, Fletcher JA, Denny CT, Lessnick SL, Linehan WM et al. (2006) Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 9, 473 484.
14. Antonescu CR, Nafa K, Segal NH, Dal Cin P Ladanyi M (2006) EWS-CREB1: a recurrent variant fusion in clear cell sarcoma - association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 12, 5356 5362.
15. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H Griffin JD (2005) Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24, 2391 2402.
16. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR Kaye FJ (2005) Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65, 7137 7144.
17. Smith MR Greene WC (1991) Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J Clin Invest 88, 1038 1042.
18. Grassmann R, Aboud M Jeang KT (2005) Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976 5985.
19. Maguire HF, Hoeffler JP Siddiqui A (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252, 842 844.
20. Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Lévy L, Buendia MA Neuveut C (2007) The hepatitis B virus X protein functionally interacts with CBP/p300 in the regulation of CREB-mediated transcription. J Biol Chem 282, 4277 4287.
21. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, DePinho RA, Montminy M Cantley LC (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642 1646.
22. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, Tsuchiya Y, Min L, Doi J, Miyauchi A et al. (2006) Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 273, 2730 2748.
23. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP et al. (2006) A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38, 794 800.
24. Crans-Vargas HN, Landaw EM, Bhatia S, Sandusky G, Moore TB Sakamoto KM (2002) Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood 99, 2617 2619.
25. Åman P (2005) Fusion oncogenes in tumor development. Semin Cancer Biol 15, 236 243.
26. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A Thomas G (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4, 341 345.
27. Hallor KH, Mertens F, Jin Y, Meis-Kindblom JM, Kindblom LG, Behrendtz M, Kalen A, Mandahl N Panagopoulos I (2005) Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 44, 97 102.
28. Brindle P, Linke S Montminy M (1993) Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors. Nature 364, 821 824.
29. Quinn PG (1993) Distinct activation domains within cAMP response element-binding protein (CREB) mediate basal and cAMP-stimulated transcription. J Biol Chem 268, 16999 17009.
30. Asahara H, Santoso B, Du Guzman EK, Cole PA, Davidson I Montminy M (2001) Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol Cell Biol 21, 7892 7900.
31. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR Goodman RH (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855 859.
32. Kundu TK, Palhan VB, Wang Z, An W, Cole PA Roeder RG (2000) Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol Cell 6, 551 561.
33. Felinski EA Quinn PG (1999) The CREB constitutive activation domain interacts with TATA-binding protein-associated factor 110 (TAF110) through specific hydrophobic residues in one of the three subdomains required for both activation and TAF110 binding. J Biol Chem 274, 11672 11678.
34. Nakajima T, Uchida C, Anderson SF, Parvin JD Montminy M (1997) Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev 11, 738 747.
35. Saluja D, Vassallo MF Tanese N (1998) Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators. Mol Cell Biol 18, 5734 5743.
36. Li KK Lee KA (1998) MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription. Oncogene 16, 1325 1331.
37. Bosilevac JM, Olsen RJ, Bridge JA Hinrichs SH (1999) Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J Biol Chem 274, 34811 34818.
38. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El Naggar A, Griffin JD et al. (2003) t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33, 208 213.
39. Enlund F, Behboudi A, Andren Y, Oberg C, Lendahl U, Mark J Stenman G (2004) Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 292, 21 28.
40. Behboudi A, Winnes M, Gorunova L, van den Oord JJ, Mertens F, Enlund F Stenman G (2005) Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion. Genes Chromosome Cancers 43, 202 205.
41. Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, Chen CH, Song C, Garza D Labow M (2004) Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr Biol 14, 2156 2161.
42. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR III., Takemori H et al. (2004) The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61 74.
43. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P et al. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109 1111.
44. Siu YT, Chin KT, Siu KL, Choy EYW, Jeang KT Jin DY (2006) TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol 80, 7052 7059.
45. Komiya T, Park Y, Modi S, Coxon AB, Oh H Kaye FJ (2006) Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25, 6128 6132.
46. Jeang KT, Boros I, Brady J, Radonovich M Khoury G (1988) Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J Virol 62, 4499 4509.
47. Zhao LJ Giam CZ (1991) Interaction of the human T-cell lymphotrophic virus (HTLV) type I transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-1 enhancer. Proc Natl Acad Sci USA 88, 11445 11449.
48. Koga H, Ohshima T Shimotohno K (2004) Enhanced activation of Tax-dependent transcription of human T-cell leukemia virus type I (HTLV-1) long terminal repeat by TORC3. J Biol Chem 279, 52978 52983.
49. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77, 7415 7419.
50. Yoshida M, Seiki M, Yamaguchi K Takatsuki K (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 81, 2534 2537.
51. Yoshida M (2001) Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19, 475 496.
52. Gatza ML, Watt JC Marriott SJ (2003) Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22, 5141 5149.
53. Kashanchi F Brady JN (2005) Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 24, 5938 5951.
54. Tie F, Adya N, Greene WC Giam CZ (1996) Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat. J Virol 70, 8368 8374.
55. Jin DY Jeang KT (1997) HTLV-I Tax self association in optimal trans-activation function. Nucl Acids Res 25, 379 388.
56. Franklin AA, Kubik MF, Uittenbogaard MN, Brauweiler A, Utaisincharoen P, Matthews MA, Dynan WS, Hoeffler JP Nyborg JK (1993) Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) and cAMP response element-binding protein (CREB). J Biol Chem 268, 21225 21231.
57. Semmes OJ Jeang KT (1995) Definition of a minimal activation domain in human T-cell leukemia virus type I Tax. J Virol 69, 1827 1833.
58. Kimzey AL Dynan WS (1998) Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking. J Biol Chem 273, 13768 13775.
59. Ching YP, Chun AC, Chin KT, Zhang ZQ, Jeang KT Jin DY (2004) Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology 1, 18.
60. Wagner S Green MR (1993) HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262, 395 399.
61. Perini G, Wagner S Green MR (1995) Recognition of bZIP proteins by the human T-cell leukemia virus transactivator Tax. Nature 376, 602 605.
62. Baranger AM, Palmer CR, Hamm MK, Gleber HA, Brauweiler A, Nyborg JK Schepartz A (1995) Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature 376, 606 608.
63. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih HM, Connor LM, Marriott SJ Goodman RH (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380, 642 646.
64. Giebler HA, Loring JE, van Orden K, Colgin MA, Garrus JE, Escudero KW, Brauweiler A Nyborg JK (1997) Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol 17, 5156 5164.
65. Bex F, Yin MJ, Burny A Gaynor RB (1998) Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol 18, 2392 2405.
66. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, Nakatani Y Brady JN (1999) PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol 19, 8136 8145.
67. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, Nakatani Y Giam CZ (2000) p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 275, 11852 11857.
68. Lu H, Pise-Masison CA, Fletcher TM, Schiltz RL, Nagaich AK, Radonovich M, Hager G, Cole PA Brady JN (2002) Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template. Mol Cell Biol 22, 4450 4462.
69. Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR Greene WC (1988) HTLV-I Tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241, 1652 1655.
70. Fujii M, Sassone CP Verma IM (1988) c-fos promoter trans-activation by the Tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 85, 8526 8530.
71. Chu ZL, DiDonato JA, Hawiger J Ballard DW (1999) The Tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ. J Biol Chem 274, 15297 15300.
72. Jin DY, Giordano V, Kibler KV, Nakano H Jeang KT (1999) Role of adaptor function in oncoprotein-mediated activation of NF-κB: HTLV-I Tax interacts directly with IκB kinase γ. J Biol Chem 274, 17402 17405.
73. Harhaj EW Sun SC (1999) IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 274, 22911 22914.
74. Hall WW Fujii M (2005) Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 24, 5965 5975.
75. Semmes OJ Jeang KT (1992) Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins. J Virol 66, 7183 7192.
76. Akagi T, Ono H, Nyunoya H Shimotohno K (1997) Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 14, 2071 2078.
77. Rosin O, Koch C, Schmitt I, Semmes OJ, Jeang KT Grassmann R (1998) A human T-cell leukemia virus Tax variant incapable of activating NF-κB retains its immortalizing potential for primary T-lymphocytes. J Biol Chem 273, 6698 6703.
78. Matsumoto K, Shibata H, Fujisawa JI, Inoue H, Hakura A, Tsukahara T Fujii M (1997) Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol 71, 4445 4451.
79. Jin DY, Spencer F Jeang KT (1998) Human T-cell leukemia virus type I oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93, 81 91.
80. Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F, Grassmann R Jeang KT (1998) Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol 18, 3620 3632.
81. Lemoine FJ Marriott SJ (2002) Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax. Oncogene 21, 7230 7234.
82. Haoudi A, Daniels RC, Wong E, Kupfer G Semmes OJ (2003) Human T-cell leukemia virus-I Tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J Biol Chem 278, 37736 37744.
83. Jeang KT, Giam CZ, Majone F Aboud M (2004) Life, death, and Tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem 279, 31991 31994.
84. Peloponese JM Jr., Haller K, Miyazato A Jeang KT (2005) Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc Natl Acad Sci USA 102, 18974 18979.
85. Kuo YL Giam CZ (2006) Activation of the anaphase promoting complex by HTLV-1 Tax leads to senescence. EMBO J 25, 1741 1752.
86. Ching YP, Chan SF, Jeang KT Jin DY (2006) Retroviral oncoprotein Tax targets coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol 8, 717 724.
87. Barnabas S, Hai T Andrisani OM (1997) The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem 272, 20684 20690.
88. Perini G, Oetjen E Green MR (1999) The hepatitis B pX protein promotes dimerization and DNA-binding of cellular basic region/leucine zipper proteins by targeting the conserved basic region. J Biol Chem 274, 13970 13977.
89. McGarrity TJ Amos C (2006) Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci 63, 2135 2144.
90. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR Hardie DG (2003) Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2, 28.
91. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M Carling D (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004 2008.
92. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA Cantley LC (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101, 3329 3335.
93. Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18, 598 608.
94. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X Bertherat J (2002) Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann NY Acad Sci 968, 65 74.